Mammalian Cell Fermentation Technology Market - Top Companies and Manufacturers

In the News

• Shanghai Henlius Biotech, Inc. stated that it has signed an exclusive licence deal with Fosun Pharma to commercialise the anti-PD-1 monoclonal antibody (mAb) HANSIZHUANG, which Henlius independently created, in the US. The conditions of the deal state that Henlius will continue to be in charge of development, manufacture, and supply, while Fosun Pharma will have the authority to commercialise HANSIZHUANG in the US following approval.
• A highly pure cystine peptide is now available from Evonik to help with formulation issues with cell culture media and other methods that are utilized in the creation and manufacturing of biopharmaceuticals. Globally accessible, cQrex AC is a chemically defined, highly soluble source of L-cystine that allows cells to get enough of this essential amino acid.